Bruce E. Murdoch is a neurologist based in St Lucia, QLD, Australia. Neurology can sound big and scary, but most visits end up being about practical things like movement, balance, speech, and how the brain and nerves are doing day to day.
Bruce works with people who have a range of neurological conditions. This can include movement disorders such as Parkinson’s disease and drug-induced dyskinesia. At times, patients also come in with issues like dysarthria, where speech can become harder to control or sound different. Balance and coordination problems are another big focus, including different types of hereditary ataxia and spinocerebellar ataxia.
Some people see Bruce after an injury too. Traumatic brain injury can affect thinking, mood, movement, and overall function, and recovery often takes time. In other cases, appointments are linked to brain or cerebellar tumours, such as posterior fossa tumours and medulloblastoma, where ongoing nervous system care can be part of the bigger treatment plan.
He also looks after children and adults living with metabolic conditions, including classic galactosemia. This type of condition needs steady medical follow-up, and it helps to have a clear plan for what to watch for and how to manage symptoms over time.
Over the years, his clinical experience is built around supporting people through both long-term conditions and changes that happen after new symptoms start. That might mean adjusting to new limits, dealing with flare-ups, or working out how symptoms fit together and what can realistically be helped.
Bruce’s education includes training in neurology, with a focus on understanding how the nervous system works. He uses that training to guide care in a calm, grounded way, without rushing. Even when the situation feels complex, the goal is usually to keep things simple: get a better picture, talk through options, and make a plan that makes sense.
When it’s relevant, he keeps up with research and new care directions. Clinical trials can be an option for some people, but there isn’t set public detail here on specific trials. In many cases, the main step is still a solid assessment and making sure the right next move is clear.